Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Eyenovia Inc (EYEN)

Eyenovia Inc (EYEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Eyenovia, Inc. Secures Debt Payment Deferral from Avenue Capital to Facilitate Strategic Restructuring Quiver Quantitative, Inc. - Fri Nov 22, 4:16PM CST

Avenue Capital defers Eyenovia's debt payments until February 2025 as the company explores strategic alternatives and reduces costs.Quiver AI SummaryEyenovia, Inc., an ophthalmic technology company, announced...

EYEN : 0.1076 (+2.38%)
Eyenovia Provides Update on Restructuring Efforts GlobeNewswire - Fri Nov 22, 6:00AM CST

EYEN : 0.1076 (+2.38%)
Eyenovia, Inc. Announces Discontinuation of CHAPERONE Study After Efficacy Endpoint Not Met Quiver Quantitative, Inc. - Fri Nov 15, 4:16PM CST

Eyenovia's CHAPERONE study is discontinued after failing its primary efficacy endpoint; further evaluation and strategic options are planned.Quiver AI SummaryEyenovia, Inc. announced the discontinuation...

EYEN : 0.1076 (+2.38%)
Eyenovia Provides Update on Phase 3 CHAPERONE Study GlobeNewswire - Fri Nov 15, 6:00AM CST

EYEN : 0.1076 (+2.38%)
Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Tue Nov 12, 3:05PM CST

EYEN : 0.1076 (+2.38%)
Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th GlobeNewswire - Thu Nov 7, 6:00AM CST

EYEN : 0.1076 (+2.38%)
Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet® GlobeNewswire - Wed Oct 23, 6:00AM CDT

EYEN : 0.1076 (+2.38%)
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo GlobeNewswire - Wed Oct 16, 6:00AM CDT

EYEN : 0.1076 (+2.38%)
Formosa Pharmaceuticals Announces Licensing Agreement with Eyenovia, Inc., for the Commercialization of APP13007 for the Treatment of Inflammation and Pain Following Ocular Surgery PR Newswire - Wed Aug 16, 2023

/PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has entered into a licensing agreement with...

EYEN : 0.1076 (+2.38%)
Eyenovia Expands Its US Manufacturing Capabilities ACCESSWIRE - Tue Jun 6, 2023

Eyenovia is stepping up the capabilities of its facilities and taking advantage of the thriving innovation culture and expertise in Reno, Nevada, and Redwood City, California

EYEN : 0.1076 (+2.38%)

Barchart Exclusives

3 High-Yielding Dividend Kings to Boost Your Income in 2025 and Beyond Barchart - Fri Nov 22, 6:00PM CST
These three high-quality companies are currently on sale, offering elevated yields that appeal to dividend growth investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot